Novo Nordisk is committed to working with the NHS to improve patient healthcare and welcomes the recent move from the Department of Health and the Association of British Pharmaceutical Industry (ABPI) which formalises how the NHS and the pharmaceutical industry work together in a more transparent business-to-business manner for the benefit of patients under the Joint Working framework.
Joint Working is defined by the Department of Health in the Best Practice Guidance on the Joint Working, as "Situations where, for the benefit of patients, one or more pharmaceutical companies and the NHS pool skills, experience and/or resources for the joint development and implementation of patient-centered projects and share a commitment to successful delivery."
Please find below details of Novo Nordisk's Joint Working Projects.
Projects commenced 2016 onwards
This page is intended for members of the UK public
UK/WB/1013/0029(7) December 2017